Zhang Qiankun, Zhang Ting
From the Department of Rheumatology, Lishui Center Hospital, Lishui, Zhejiang, China (QZ); and Department of Rheumatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (TZ).
Am J Phys Med Rehabil. 2016 May;95(5):366-71. doi: 10.1097/PHM.0000000000000403.
The main objective of this study was to observe whether synovial fluid aspiration of the knee joint compared to no aspiration, before and after 5 weekly injections of intra-articular hyaluronan, provides an improvement in knee pain and physical function.
Patients were randomized to an arthrocentesis group (n = 92) or a nonarthrocentesis group (n = 88). In the arthrocentesis group, knee joints were maximally aspirated before each hyaluronan administration. In the nonarthrocentesis group, synovial fluid was not removed. Hyaluronan was injected into the knee joints once a week for 5 weeks. Patients were followed up for 25 weeks. Outcome measures included patient pain (using the 100-mm visual analog scale [VAS] during a 50-foot walking test), Western Ontario McMaster University Osteoarthritis Index (WOMAC) function scores, and overall effectiveness evaluated by patients and investigators on a scale of 1 to 6.
The arthrocentesis group showed significantly greater improvement from baseline to week 25 in VAS pain (P < 0.001) and WOMAC function scores (P < 0.001) than the nonarthrocentesis group. However, the differences of patient and investigator assessment of effectiveness did not achieve significance.
Synovial fluid drainage before injection of intra-articular hyaluronan significantly improved VAS pain and WOMAC function scores in patients with knee osteoarthritis, however, the differences of patient and investigator assessment did not achieve significance.
本研究的主要目的是观察在每周进行5次关节腔内注射透明质酸之前和之后,与不进行抽液相比,膝关节滑膜抽液是否能改善膝关节疼痛和身体功能。
将患者随机分为关节穿刺组(n = 92)或非关节穿刺组(n = 88)。在关节穿刺组中,每次注射透明质酸前均对膝关节进行最大程度抽液。在非关节穿刺组中,不抽取滑液。每周向膝关节注射一次透明质酸,共注射5周。对患者进行25周的随访。观察指标包括患者疼痛程度(在50英尺步行测试中使用100毫米视觉模拟量表[VAS])、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)功能评分,以及患者和研究者根据1至6分制评估的总体疗效。
与非关节穿刺组相比,关节穿刺组从基线到第25周VAS疼痛评分(P < 0.001)和WOMAC功能评分(P < 0.001)改善更为显著。然而,患者和研究者对疗效评估的差异未达到显著水平。
关节腔内注射透明质酸前进行滑膜抽液可显著改善膝关节骨关节炎患者的VAS疼痛评分和WOMAC功能评分,然而,患者和研究者评估的差异未达到显著水平。